Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001601830-25-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-15 | RXRX | Khan Najat | Chief R, D Commercial Off, Dir | F - Tax | $4.25 | -3,796 | 708.6K | -0.5% | -$16.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-15 | F | D | 3,796 | $4.25 | 708,585 | D | — | — |